Chidamide is a targeted antitumor drug:
It is an original innovative anticancer drug indicated for specific types of cancer.
It exerts a therapeutic effect in inhibiting the tumor cell cycle as well as tumor recurrence and metastasis.
It has the function of inducing the differentiation of tumor stem cells, which can suppress tumor metastasis and recurrence.
Attention should be paid to adverse reactions during chidamide administration, such as reductions in platelets, leukocytes and other blood cells, as well as systemic symptoms including general fatigue and fever.
